58 related articles for article (PubMed ID: 23576690)
1. Early diagnostic biomarkers for esophageal adenocarcinoma--the current state of play.
Shah AK; Saunders NA; Barbour AP; Hill MM
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1185-209. PubMed ID: 23576690
[TBL] [Abstract][Full Text] [Related]
2. Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma.
Antonowicz S; Bodai Z; Wiggins T; Markar SR; Boshier PR; Goh YM; Adam ME; Lu H; Kudo H; Rosini F; Goldin R; Moralli D; Green CM; Peters CJ; Habib N; Gabra H; Fitzgerald RC; Takats Z; Hanna GB
Nat Commun; 2021 Mar; 12(1):1454. PubMed ID: 33674602
[TBL] [Abstract][Full Text] [Related]
3. Using saliva epigenetic data to develop and validate a multivariable predictor of esophageal cancer status.
Stone TC; Ward V; Hogan A; Ho KMA; Wilson A; McBain H; Duku M; Wolfson P; Cheung S; Rosenfeld A; Lovat LB;
Epigenomics; 2024 Jan; 16(2):109-125. PubMed ID: 38226541
[No Abstract] [Full Text] [Related]
4. Risk prediction models for esophageal cancer: A systematic review and critical appraisal.
Li H; Sun D; Cao M; He S; Zheng Y; Yu X; Wu Z; Lei L; Peng J; Li J; Li N; Chen W
Cancer Med; 2021 Oct; 10(20):7265-7276. PubMed ID: 34414682
[TBL] [Abstract][Full Text] [Related]
5. Cancer Methylation Biomarker Detection in an Automated, Portable, Multichannel Magnetofluidic Platform.
Hasnain AC; Stark A; Trick AY; Ma K; Hsieh K; Cheng Y; Meltzer SJ; Wang TH
ACS Nano; 2024 May; 18(19):12105-12116. PubMed ID: 38669469
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric High-Content Cell Painting Identifies Copper Ionophores as Selective Modulators of Esophageal Cancer Phenotypes.
Hughes RE; Elliott RJR; Li X; Munro AF; Makda A; Carter RN; Morton NM; Fujihara K; Clemons NJ; Fitzgerald R; O'Neill JR; Hupp T; Carragher NO
ACS Chem Biol; 2022 Jul; 17(7):1876-1889. PubMed ID: 35696676
[TBL] [Abstract][Full Text] [Related]
7. Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma.
Chiam K; Wang T; Watson DI; Mayne GC; Irvine TS; Bright T; Smith L; White IA; Bowen JM; Keefe D; Thompson SK; Jones ME; Hussey DJ
J Gastrointest Surg; 2015 Jul; 19(7):1208-15. PubMed ID: 25943911
[TBL] [Abstract][Full Text] [Related]
8. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E
Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
[TBL] [Abstract][Full Text] [Related]
9. Development of EndoScreen Chip, a Microfluidic Pre-Endoscopy Triage Test for Esophageal Adenocarcinoma.
Webster JA; Wuethrich A; Shanmugasundaram KB; Richards RS; Zelek WM; Shah AK; Gordon LG; Kendall BJ; Hartel G; Morgan BP; Trau M; Hill MM
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201241
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of TWIST-Positive Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma.
Lee HJ; Kim GH; Park SJ; Kwon CH; Lee MW; Lee BE; Baek DH; I H
Gut Liver; 2021 Jul; 15(4):553-561. PubMed ID: 33293482
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.
Grady WM; Yu M; Markowitz SD
Gastroenterology; 2021 Feb; 160(3):690-709. PubMed ID: 33279516
[TBL] [Abstract][Full Text] [Related]
12. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers.
Grady WM; Yu M; Markowitz SD; Chak A
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2486-2494. PubMed ID: 33093162
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Methylation of LINE-1 Transposable Elements: A Search for Cancer Biomarkers.
Ponomaryova AA; Rykova EY; Gervas PA; Cherdyntseva NV; Mamedov IZ; Azhikina TL
Cells; 2020 Sep; 9(9):. PubMed ID: 32887319
[TBL] [Abstract][Full Text] [Related]
14. New Understanding of the Relevant Role of LINE-1 Retrotransposition in Human Disease and Immune Modulation.
Zhang X; Zhang R; Yu J
Front Cell Dev Biol; 2020; 8():657. PubMed ID: 32850797
[TBL] [Abstract][Full Text] [Related]
15. CircRNA
Luo G; Li R; Li Z
Int J Clin Exp Pathol; 2018; 11(8):4188-4196. PubMed ID: 31949813
[TBL] [Abstract][Full Text] [Related]
16. Clinical diagnostic value of digestive endoscopic narrow-band imaging in early esophageal cancer.
Su Z; Wang L; Wei S; Wei X; Kong Y; Wang W; Guo R; Shi X
Oncol Lett; 2019 Jun; 17(6):5481-5486. PubMed ID: 31186767
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus.
Shah AK; Hartel G; Brown I; Winterford C; Na R; Cao KL; Spicer BA; Dunstone MA; Phillips WA; Lord RV; Barbour AP; Watson DI; Joshi V; Whiteman DC; Hill MM
Mol Cell Proteomics; 2018 Dec; 17(12):2324-2334. PubMed ID: 30097534
[TBL] [Abstract][Full Text] [Related]
18. Barrett's oesophagus: how should we manage it?
Old OJ; Almond LM; Barr H
Frontline Gastroenterol; 2015 Apr; 6(2):108-116. PubMed ID: 28839797
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer.
Hou X; Wen J; Ren Z; Zhang G
Oncotarget; 2017 Jun; 8(26):43571-43578. PubMed ID: 28388588
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNA profile in esophageal adenocarcinoma.
Zhang K; Wu X; Wang J; Lopez J; Zhou W; Yang L; Wang SE; Raz DJ; Kim JY
Am J Cancer Res; 2016; 6(11):2713-2721. PubMed ID: 27904783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
